From:  The customization paradox: Why geometric precision is no substitute for biological integration?

 Practical comparison points when choosing off-the-shelf versus patient-specific additively manufactured implants (AM).

DomainOff-the-shelf
(strengths/typical limits)
Patient-specific/AM
(potential gains/new risks)
Evidence baseLarge registries; established survivorship; predictable instrumentationSmaller series; indication creep; often mid-term parity
BiomechanicsWell-characterised stiffness; known stress-shielding patternsStiffness tuning via lattices; fatigue/process variability
Biological integrationProven surface finishes/coatings; predictable osseointegrationPorosity/graded structures; vascular barrier risk; assessment heterogeneity
Revision strategyStandardised explant tools; modular exchangeOver-conformity and deep ingrowth complicate removal; must design exit strategy
Workflow & costShort planning time; lower unit costVirtual surgical planning (VSP)/design iterations; manufacturing lead time; higher unit cost; QA burden
Regulatory & liabilityMDR/FDA cleared for broad use; manufacturer liability“Custom-made” exemption status; increased institutional & surgeon liability for design